Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

Laurence Albiges, MD, PhD, and Toni K. Choueiri, MD, on Metastatic RCC: Perspectives on the Carmena Trial

Posted: Monday, June 25, 2018

Laurence Albiges, MD, PhD, of Gustave Roussy, and Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discuss the implications of this study’s potentially practice-changing finding that nephrectomy is no longer the standard of care for patients with metastatic renal cell carcinoma.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.